Pirro, Federico, et al. “Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost Per Responder Comparison in Patients With Psoriasis in Italy”. Dermatology Practical & Conceptual, vol. 15, no. 1, Jan. 2025, p. 4838, https://doi.org/10.5826/dpc.1501a4838.